Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
NonExomics
NonExomics, Inc. is a genomics company pioneering the discovery of novel drug targets by mining the entire human genome, beyond the conventional 1-2% gene regions. Using a proprietary, patent-pending…
NonExomics
NonExomics, Inc. is a genomics company pioneering the discovery of novel drug targets by mining the entire human genome, beyond the conventional 1-2% gene regions. Using a proprietary, patent-pending…
TL;DR
Focus: Discovery of noncanonical (nonexomic) proteins as drug targets using multi-omics + AI
Platform: Proprietary, partly patent-pending ML platform integrating genomics, transcriptomics, proteomics
Claims: Validated ~250,000 novel proteins; ~3,000 prioritized targets linked to 1,365 diseases (company-stated)
Founding / HQ: Founded by scientists from Harvard and Cambridge; incorporated 2021; Acton/Boston area
Illumina Accelerator